Hypertension in nursing home patients

Journal of Human Hypertension

Volumn 12, Issue 2, 1998, Pages 117-121

  Trilling, J S ^a   Froom, J ^a   Gomolin, I H ^a   Yeh, S S ^a   Grimson, R C ^a   Nevin, S ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Aged; Comorbidity; Hypertension; Medications; Nursing homes

Indexed keywords

ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD DISEASE; BLOOD PRESSURE REGULATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GERIATRIC CARE; HEART DISEASE; HIP FRACTURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEOPLASM; NURSING HOME; RESIDENTIAL CARE; SKIN DISEASE;

EID: 0031965233     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000570     Document Type: Article

References (43)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA 1967; 202: 1028-1034.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1980; 213: 1143-1152.
3. United States Public Health Service Hospitals Cooperative Study Group. Treatment of mild hypertension. Results of a ten-year intervention trial. Circ Res 1977; 40 (Suppl): I98-I105.
4. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562-2571.
5. Helgeland A. Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study. Am J Med 1980; 69: 725-732.
6. Australian National Blood Pressure Study Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261-1267.
7. Hypertension Detection and Follow-up Program Cooperative Group. The effects of treatment on mortality in "mild" hypertension: results of the Hypertension Detection and Follow-up Program. N Engl J Med 1982; 307: 976-980.
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264.
9. Amery A et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-1354.
10. Stamler J. Risk factor modification trials: Implications for the elderly. Eur Heart J 1988; 9: (Suppl D): 9-53.
11. Coopo J, Warrender TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145-1151.
12. Fletcher A, Bulpitt C. Epidemiology of hypertension in the elderly. J Hypertens 1994; 12 (Suppl 6): S3-S6.
13. Sirrocco A. Nursing homes and board and care homes. Advance data from vital and health statistics: no 244. Hyattsville, Maryland: National Center for Health Statistics, 1994.
14. National Center for Health Statistics. Hing E, Sekscenski E, Strahan G. 1989. The National Nursing Home Survey; 1985 summary for the United States. Vital and Health Statistics. Series 13, No 97. DHHS Pub. No. (PHS) 89-1758. Public Health Service. Washington; US. Government Printing Office.
15. National High Blood Pressure Education Program Working Group. National high blood pressure education working group report on hypertension in the elderly. Hypertension 1994; 23: 275-288.
16. Bild DE et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the cardiovascular health study. J Am Geriatr Soc 1993; 41: 1047-1056.
17. Public: Health Service. The International Classification of Diseases 9th Revision Clinical Modification ICD-9-CM. DHSS Publication No. (PHS) 80-1260. Washington 1980.
18. Lair T, Lefkowitz D. Mental health and functional status of residents of nursing and personal care homes. (DHHS Publication No. (PHS) 90-3470. National Medical Expenditure Survey Research Findings 7, Agency for Health Care Policy and Research. Rockville, MD: Public Health Service. 1990.
19. Moser M. Controversies in the mangement of hypertension. Am Fam Physician 1990; 41: 1449-1460.
20. Materson BJ et al. Single drug therapy for hypertension in men. N Engl J Med 1993; 328: 914-921.
21. Neaton JD et al. Treatment of Mild Hypertension Study: final results. JAMA 1993; 270: 713-724.
22. Curb JD et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-1892.
23. Monane M et al. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension 1995; 25: 1045-1051.
24. Hamet P, Gong L. Antihypertensive therapy debate: contribution from the Shanghai Trial Of Nifedipine in the elderly (STONE). J Hypertens 1996; 14 (Suppl): S9-S14.
25. Gong L et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-1245.
26. Celis H et al. Antihypertensive therapy in older patients with isolated systolic hypertension: the Syst-Eur experience in general practice. The Syst-Eur Investigators. Fam Pract 1996; 13: 138-143.
27. Psalty BM et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
28. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA 1995; 274: 654-655.
29. Pahor M et al. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996; 347: 1061-1065.
30. Pahor M et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-497.
31. Borhani NO et al. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996; 276: 785-791.
32. Chobanian AV. Calcium channel blockers. Lessons learned from MIDAS and other clinical trials. JAMA 1996; 276: 829-830.
33. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organization and the International Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens 1997; 15: 105-115.
34. Johnson AG et al. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmac 1993; 35: 455-459.
35. Gerber JG, LoVerde M, Bvvny RL, Nies AS. The antihypertensive effect of hydrochlorthiazide is not prostacyclin dependent. Clin Pharmac Ther 1990; 48: 424-430.
36. Hardy BG et al. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine. Br J Cin Pharmacol 1988; 26: 557-562.
37. Gurwitz JH et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994; 272: 781-786.
38. Avorn J, Gurwitz JH. Drug use in the Nursing Home. Ann Intern Med 1995; 123: 195-204.
39. Beers MH et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-689.
40. Ackermann RJ, von Bremen BM. Reducing polypharmacy in the nursing home: an activist approach. J Am Board Fam Pract 1995; 8: 195-205.
41. Lapierre G, Pevonka P, Stewart RB, Yost RL. Evaluation of hypertensive therapy in a skilled nursing facility. Drug Intell Clin Pharm 983; 17: 39-44.
42. Nolan L, O'Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age Ageing 1989; 18: 52-56.
43. Mulrow CD et al. Function and medical comorbidity in South Texas nursing home residents: variations by ethnic groups. J Am Geriatr Soc 1996; 44: 279-284.